A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells

Immunity

Volumn 22, Issue 3, 2005, Pages 295-304

  Freud, Aharon G ^a   Becknell, Brian ^a   Roychowdhury, Sameek ^a   Mao, Hsiaoyin C ^a   Ferketich, Amy K ^a   Nuovo, Gerard J ^a   Hughes, Tiffany L ^a   Marburger, Trent B ^a   Sung, John ^a   Baiocchi, Robert A ^b,c   Guimond, Martin ^a   Caligiuri, Michael A ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD56 ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 2;

ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CONTROLLED STUDY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 20144371569     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2005.01.013     Document Type: Article

References (42)

1. M.B. Alimzhanov, D.V. Kuprash, M.H. Kosco-Vilbois, A. Luz, R.L. Turetskaya, A. Tarakhovsky, K. Rajewsky, S.A. Nedospasov, and K. Pfeffer Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice Proc. Natl. Acad. Sci. USA 94 1997 9302 9307
2. I. Barao, D. Hudig, and J.L. Ascensao IL-15-mediated induction of LFA-1 is a late step required for cytotoxic differentiation of human NK cells from CD34+Lin- bone marrow cells J. Immunol. 171 2003 683 690
3. A. Bendelac, and D.T. Fearon Innate pathways that control acquired immunity Curr. Opin. Immunol. 9 1997 1 3
4. I.M. Bennett, O. Zatsepina, L. Zamai, L. Azzoni, T. Mikheeva, and B. Perussia Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12 J. Exp. Med. 184 1996 1845 1856
5. B. Blom, S. Ho, S. Antonenko, and Y.J. Liu Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells J. Exp. Med. 192 2000 1785 1796
6. M.A. Caligiuri, A. Zmuidzinas, T.J. Manley, H. Levine, K.A. Smith, and J. Ritz Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors J. Exp. Med. 171 1990 1509 1526
7. B. Canque, S. Camus, A. Dalloul, E. Kahn, M. Yagello, C. Dezutter-Dambuyant, D. Schmitt, C. Schmitt, and J.C. Gluckman Characterization of dendritic cell differentiation pathways from cord blood CD34(+)CD7(+) CD45RA(+) hematopoietic progenitor cells Blood 96 2000 3748 3756
8. W.E. Carson, S. Haldar, R.A. Baiocchi, C.M. Croce, and M.A. Caligiuri The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2 Proc. Natl. Acad. Sci. USA 91 1994 7553 7557
9. F. Colucci, M.A. Caligiuri, and J.P. Di Santo What does it take to make a natural killer? Nat. Rev. Immunol. 3 2003 413 425
10. M.A. Cooper, T.A. Fehniger, and M.A. Caligiuri The biology of human natural killer-cell subsets Trends Immunol. 22 2001 633 640
11. M.A. Cooper, T.A. Fehniger, A. Fuchs, M. Colonna, and M.A. Caligiuri NK cell and DC interactions Trends Immunol. 25 2004 47 52
12. T.A. Fehniger, E.M. Bluman, M.M. Porter, E. Mrozek, M.A. Cooper, J.B. VanDeusen, S.R. Frankel, W. Stock, and M.A. Caligiuri Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy J. Clin. Invest. 106 2000 117 124
13. T.A. Fehniger, M.A. Cooper, G.J. Nuovo, M. Cella, F. Facchetti, M. Colonna, and M.A. Caligiuri CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity Blood 101 2003 3052 3057
14. G. Ferlazzo, D. Thomas, S.L. Lin, K. Goodman, B. Morandi, W.A. Muller, A. Moretta, and C. Munz The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic J. Immunol. 172 2004 1455 1462
15. A. Galy, M. Travis, D. Cen, and B. Chen Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset Immunity 3 1995 459 473
16. J. Hackett Jr., M. Bennett, and V. Kumar Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor J. Immunol. 134 1985 3731 3738
17. K. Iizuka, D.D. Chaplin, Y. Wang, Q. Wu, L.E. Pegg, W.M. Yokoyama, and Y.X. Fu Requirement for membrane lymphotoxin in natural killer cell development Proc. Natl. Acad. Sci. USA 96 1999 6336 6340
18. L.L. Lanier, H. Spits, and J.H. Phillips The developmental relationship between NK cells and T cells Immunol. Today 13 1992 392 395
19. K. Lassoued, C.A. Nunez, L. Billips, H. Kubagawa, R.C. Monteiro, T.W. LeBlen, and M.D. Cooper Expression of surrogate light chain receptors is restricted to a late stage in pre-B cell differentiation Cell 73 1993 73 86
20. R.E. Mebius Organogenesis of lymphoid tissues Nat. Rev. Immunol. 3 2003 292 303
21. R.E. Mebius, P. Rennert, and I.L. Weissman Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells Immunity 7 1997 493 504
22. J.S. Miller, K.A. Alley, and P. McGlave Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor Blood 83 1994 2594 2601
23. J.S. Miller, V. McCullar, M. Punzel, I.R. Lemischka, and K.A. Moore Single adult human CD34(+)/Lin-/CD38(-) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells Blood 93 1999 96 106
24. E. Mrozek, P. Anderson, and M.A. Caligiuri Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells Blood 87 1996 2632 2640
25. A. Nagler, L.L. Lanier, and J.H. Phillips Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo J. Exp. Med. 171 1990 1527 1533
26. G.J. Nuovo, T.W. Plaia, S.A. Belinsky, S.B. Baylin, and J.G. Herman In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis Proc. Natl. Acad. Sci. USA 96 1999 12754 12759
27. C. Queen, W.P. Schneider, H.E. Selick, P.W. Payne, N.F. Landolfi, J.F. Duncan, N.M. Avdalovic, M. Levitt, R.P. Junghans, and T.A. Waldmann A humanized antibody that binds to the interleukin 2 receptor Proc. Natl. Acad. Sci. USA 86 1989 10029 10033
28. E.E. Rosmaraki, I. Douagi, C. Roth, F. Colucci, A. Cumano, and J.P. Di Santo Identification of committed NK cell progenitors in adult murine bone marrow Eur. J. Immunol. 31 2001 1900 1909
29. L. Ruggeri, M. Capanni, E. Urbani, K. Perruccio, W.D. Shlomchik, A. Tosti, S. Posati, D. Rogaia, F. Frassoni, and F. Aversa Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 2002 2097 2100
30. A. Shibuya, H. Kojima, K. Shibuya, K. Nagayoshi, T. Nagasawa, and H. Nakauchi Enrichment of interleukin-2-responsive natural killer progenitors in human bone marrow Blood 81 1993 1819 1826
31. S. Sivori, C. Cantoni, S. Parolini, E. Marcenaro, R. Conte, L. Moretta, and A. Moretta IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors Eur. J. Immunol. 33 2003 3439 3447
32. H. Spits, B. Blom, A.C. Jaleco, K. Weijer, M.C. Verschuren, J.J. van Dongen, M.H. Heemskerk, and P.C. Res Early stages in the development of human T, natural killer and thymic dendritic cells Immunol. Rev. 165 1998 75 86
33. H. Suzuki, G.S. Duncan, H. Takimoto, and T.W. Mak Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain J. Exp. Med. 185 1997 499 505
34. M. Vitale, M. Della Chiesa, S. Carlomagno, C. Romagnani, A. Thiel, L. Moretta, and A. Moretta The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells Eur. J. Immunol. 34 2004 1715 1722
35. U.H. von Andrian, and T.R. Mempel Homing and cellular traffic in lymph nodes Nat. Rev. Immunol. 3 2003 867 878
36. T. Waldmann, Y. Tagaya, and R. Bamford Interleukin-2, interleukin-15, and their receptors Int. Rev. Immunol. 16 1998 205 226
37. N.S. Williams, T.A. Moore, J.D. Schatzle, I.J. Puzanov, P.V. Sivakumar, A. Zlotnik, M. Bennett, and V. Kumar Generation of lytic natural killer 1.1+, Ly-49- cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates J. Exp. Med. 186 1997 1609 1614
38. A. Wodnar-Filipowicz Flt3 ligand: role in control of hematopoietic and immune functions of the bone marrow News Physiol. Sci. 18 2003 247 251
39. A.H. Yin, S. Miraglia, E.D. Zanjani, G. Almeida-Porada, M. Ogawa, A.G. Leary, J. Olweus, J. Kearney, and D.W. Buck AC133, a novel marker for human hematopoietic stem and progenitor cells Blood 90 1997 5002 5012
40. Y. Yokota, A. Mansouri, S. Mori, S. Sugawara, S. Adachi, S. Nishikawa, and P. Gruss Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2 Nature 397 1999 702 706
41. W.M. Yokoyama, S. Kim, and A.R. French The dynamic life of natural killer cells Annu. Rev. Immunol. 22 2004 405 429
42. H. Yu, T.A. Fehniger, P. Fuchshuber, K.S. Thiel, E. Vivier, W.E. Carson, and M.A. Caligiuri Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15 Blood 92 1998 3647 3657